Therapeutic Index of Gramicidin S is Strongly Modulated by d-Phenylalanine Analogues at the β-Turn

dc.contributor.author
Solanas, Concepción
dc.contributor.author
Torre, Beatriz G. de la
dc.contributor.author
Fernández Reyes, María
dc.contributor.author
Santiveri, Clara M.
dc.contributor.author
Jiménez, M. Ángeles
dc.contributor.author
Rivas, Luis
dc.contributor.author
Jiménez, Ana I.
dc.contributor.author
Andreu Martínez, David
dc.contributor.author
Cativiela, Carlos
dc.date.issued
2019-02-25T08:52:07Z
dc.date.issued
2019-02-25T08:52:07Z
dc.date.issued
2009
dc.identifier
Solanas C, de la Torre BG, Fernández-Reyes M, Santiveri CM, Jiménez MA, Rivas L et al. Therapeutic Index of Gramicidin S is Strongly Modulated by d-Phenylalanine Analogues at the β-Turn. J Med Chem. 2009;52(3):664-74. DOI: 10.1021/jm800886n
dc.identifier
0022-2623
dc.identifier
http://hdl.handle.net/10230/36669
dc.identifier
http://dx.doi.org/10.1021/jm800886n
dc.description.abstract
Analogues of the cationic antimicrobial peptide gramicidin S (GS), cyclo(Val-Orn-Leu-D-Phe-Pro)2, with d-Phe residues replaced by different (restricted mobility, mostly) surrogates have been synthesized and used in SAR studies against several pathogenic bacteria. While all D-Phe substitutions are shown by NMR to preserve the overall beta-sheet conformation, they entail subtle structural alterations that lead to significant modifications in biological activity. In particular, the analogue incorporating D-Tic (1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) shows a modest but significant increase in therapeutic index, mostly due to a sharp decrease in hemolytic effect. The fact that NMR data show a shortened distance between the D-Tic aromatic ring and the Orn delta-amino group may help explain the improved antibiotic profile of this analogue.
dc.description.abstract
This work was supported by Ministerio de Educación y Ciencia (BIO2005-07592-CO2-02 to D.A., BFU2005-01855 and CTQ2008-0080 to M.A.J., CTQ2007-62245 to C.C.), Fondo de Investigaciones Sanitarias (PI061125 and RD 06/0021/0006 to L.R., PI040885 to D.A.), by the regional governments of Aragón (research group E40), Catalunya (SGR2005-00494), and Madrid (S-BIO-0260/2006).
dc.format
application/pdf
dc.format
application/pdf
dc.language
spa
dc.publisher
American Chemical Society (ACS)
dc.relation
Journal of Medicinal Chemistry. 2009;52(3):664-74
dc.relation
info:eu-repo/grantAgreement/ES/2PN/BIO2005-07592-CO2-02
dc.relation
info:eu-repo/grantAgreement/ES/2PN/BFU2005-01855
dc.relation
info:eu-repo/grantAgreement/ES/3PN/CTQ2008-0080
dc.relation
info:eu-repo/grantAgreement/ES/2PN/CTQ2007-62245
dc.rights
This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of medicinal chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/jm800886n
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Gramidicin S
dc.subject
Gramidicin S
dc.subject
Cationic antimicrobial peptides
dc.subject
d-Phe analogues
dc.subject
NMR
dc.subject
β-sheet structure
dc.title
Therapeutic Index of Gramicidin S is Strongly Modulated by d-Phenylalanine Analogues at the β-Turn
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)